Protein Design and Immunotherapy Group, Departament de Bioquímica i Biologia Molecular, Facultat de Biociències, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
J Alzheimers Dis. 2019;68(2):459-471. doi: 10.3233/JAD-180740.
Alzheimer's disease (AD), the most common type of dementia worldwide, is characterized by high levels of amyloid-β (Aβ) peptide and hyperphosphorylated tau protein. Genetically, the ɛ4 allele of apolipoprotein E (ApoE) has been established as the major risk factor for developing late-onset AD (LOAD), the most common form of the disease. Although the role ApoE plays in AD is still not completely understood, a differential role of its isoforms has long been known. The current review compiles the involvement of ApoE isoforms in amyloid-β protein precursor transcription, Aβ aggregation and clearance, synaptic plasticity, neuroinflammation, lipid metabolism, mitochondrial function, and tau hyperphosphorylation. Due to the complexity of LOAD, an accurate description of the interdependence among all the related molecular mechanisms involved in the disease is needed for developing successful therapies.
阿尔茨海默病(AD)是世界上最常见的痴呆症类型,其特征是高水平的淀粉样β(Aβ)肽和过度磷酸化的 tau 蛋白。从遗传学上讲,载脂蛋白 E(ApoE)的ɛ4 等位基因已被确定为发生晚发性 AD(LOAD)的主要危险因素,LOAD 是该病最常见的形式。尽管 ApoE 在 AD 中的作用尚不完全清楚,但它的同工型的作用早已为人所知。目前的综述总结了 ApoE 同工型在淀粉样前体蛋白转录、Aβ聚集和清除、突触可塑性、神经炎症、脂质代谢、线粒体功能和 tau 过度磷酸化中的作用。由于 LOAD 的复杂性,需要对涉及疾病的所有相关分子机制之间的相互依赖关系进行准确描述,以便开发出成功的治疗方法。